Skip to content
MARKETS / NASDAQ / HSIC
NASDAQ · WHOLESALE-MEDICAL, DENTAL & HOSPITAL EQUIPMENT & SUPPLIES · LARGE CAP

Henry Schein Inc. HSIC

18 fiscal years on record · USD · FY2025 reported · SEC filings only
$13.2B
▲ 4.0% YoY
$398.0M
▲ 2.1% YoY
$573.0M
▼ 18.1% YoY
In brief

What this company does

With 94 years of experience distributing health care products, it has built a base of small, mid-sized and large customers in the dental and medical markets, serving more than one million customers worldwide across dental practices, laboratories, physician practices and ambulatory surgery centers, as well as government, institutional health care clinics, home health providers and other alternate care clinics. It stocks more than 300,000 branded and Henry Schein corporate brand products through its network, with more than 5.4 million square feet of space in 38 distribution centers and 0.6 million square feet of space in 17 manufacturing facilities around the world. It conducts its business through three reportable segments: Global Distribution and Value-Added Services, which distributes national brand and corporate brand merchandise, equipment and related technical services to the global dental and medical markets and includes value-added services such as financial services, continuing education services and consulting; Global Specialty Products, which manufactures, markets and sells dental implant and biomaterial products, endodontic, orthodontic and orthopedic products and other health care-related products and services; and Global Technology, which develops and distributes practice management software, e-services and other products to health care providers.

Written from the business description in HENRY SCHEIN, INC.'s annual report to the U.S. Securities and Exchange Commission, filed 24 February 2026. Every sentence was checked against that document before publication.

Growth
USD 13.2B
Revenue, FY2025 · full 18-year series below
Revenue $B Net income $B
FY2025 · Revenue 13.2 · Net income 0.4
5B10B2008201120142017202020232025
Compound annual growth
+1.4%
+5.4%
+2.2%
+3.8%
−9.6%
−0.3%
−1.8%
+1.3%
−5.8%
+3.0%
+7.5%
+52.0%
+7.7%
+25.8%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at +5.4% a year over five years.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability
3 cents
of every revenue dollar became profit
Operating margin Net margin
FY2025 · Operating 5.0% · Net 3.2%
2%4%6%2008201120142017202020232025
ROE
FY2025 · ROE 12.0%
10%20%2008201120142017202020232025

Each USD of equity produced 12 cents of profit this year.

Cash & shareholders
USD 600.0M
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF 573.0
250.0M500.0M2008201120142017202020232025
Net buybacks $M Dividends $M
FY2025 · Dividends — · Net buybacks 600.0
200M400M2008201120142017202020232025

USD 600.0M in buybacks — 151% of the year's profit, so the payout drew on cash built up earlier.

Total assetsUSD 11.2B
EquityUSD 3.2B
CashUSD 156.0M
Gross debtUSD 3.1B
Net debtUSD 2.9B
Current ratio1.38×

Net debt stands at 90% of equity.

The 18-year record
18 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative
Metric 202520242023202220212020201920182017201620152014201320122011201020092008
Revenue $B13.212.712.312.612.410.110.09.48.911.610.610.49.68.98.57.56.56.4
Operating income $B0.70.60.60.70.90.50.70.60.70.80.70.70.70.60.60.50.50.4
EBITDA $B1.00.90.91.01.10.70.90.70.80.90.90.90.80.70.70.60.50.5
Income tax $B0.10.10.10.20.20.10.20.10.30.20.20.20.20.20.20.20.10.1
Net income $B0.40.40.40.50.60.40.70.50.40.50.50.50.40.40.40.30.30.2
Free cash flow $B0.60.70.40.50.60.60.60.60.50.60.50.50.60.40.50.40.30.3
EPS, diluted $3.273.053.163.914.452.824.653.492.573.102.855.444.934.323.973.493.442.63
Dividend / sh $··················
Payout %··················
ROE %12.011.111.715.718.612.723.318.614.517.916.816.616.015.415.214.214.4·
Shares out B0.120.120.130.130.140.140.140.150.150.160.080.080.090.090.090.090.09·

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Provenance
Company facts, as filed
How we verify · 0 failures in 88 reconciliationsAUDITED

Reconciled in 18 of 19 fiscal years. 7 checks could not be computed.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivityWholesale-Medical, Dental & Hospital Equipment & Supplies
Listed onNASDAQ
Incorporated inDelaware
Fiscal year endsDecember 26
Data on record since2008

Share this section

Download image